Last reviewed · How we verify

NCT05377177: COMBAT-SI

Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression -COMBAT-SI

Recruiting now NA Last updated 5 November 2025
What this trial tests

NA trial testing Accelerated Theta Burst Stimulation in Suicidal Ideation in 76 participants. Currently enrolling.

Timeline
2 September 2022
Primary endpoint
1 August 2029
30 July 2030

Quick facts

Lead sponsorUniversity of California, San Diego
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment76
Start date2 September 2022
Primary completion1 August 2029
Estimated completion30 July 2030
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of California, San Diego

Who can join

Adults 18 to 70, any sex, with Suicidal Ideation or Treatment-resistant Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective clinical trial to confirm the effectiveness of bilateral accelerated theta burst stimulation (aTBS) on suicidal ideation (SI), while exploring cortical inhibition measures in this treatment paradigm. In this proposed study, the investigators will evaluate the anti-suicidal effects of bilateral aTBS over the DLPFC compared to accelerated intermittent theta burst stimulation (aiTBS) over the left DLPFC in participants with TRD and SI. Additionally, the investigators aim to identify neurophysiological targets through which bilateral aTBS induces remission of SI in TRD differentially from aiTBS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Accelerated Theta Burst Stimulation

Trials testing the same drug.

Other recruiting trials for Suicidal Ideation

Currently open trials in the same condition.

Other University of California, San Diego trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05377177.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing